Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Seiki

Showing results (41-50 of 235) with videos related to

Pageof 24
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 1984
[Adult T-cell leukemia virus (ATLV or HTLV) proviral DNA for the classification of T-cell malignancies]K Yamaguchi, K Takatsuki, M Seiki, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1984
Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the diseaseM Yoshida, M Seiki, K Yamaguchi, et al.
Genome|January 1, 1989
Molecular mechanisms of regulation of HTLV-1 gene expression and its association with leukemogenesisM Yoshida, J Inoue, J Fujisawa, et al.
FEBS Letters|February 3, 1997
Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activatorY Okumura, H Sato, M Seiki, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Cell type-specific involvement of furin in membrane type 1 matrix metalloproteinase-mediated progelatinase A activationT Sato, T Kondo, M Seiki, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1988
Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type IM Seiki, J Inoue, M Hidaka, et al.
Clinical & Experimental Metastasis|March 10, 2001
Heat shock-mediated transient increase in intracellular 3',5'-cyclic AMP results in tumor specific suppression of membrane type 1-matrix metalloproteinase production and progelatinase A activationY Sawaji, T Sato, M Seiki, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 1, 1995
[Expression of membrane-type matrix metalloproteinase (MT-MMP) and activation of MMP-2 in lung cancer]M Tokuraku, H Sato, Y Watanabe, et al.
Journal of Virology|August 1, 1992
Epstein-Barr virus BZLF1 transactivator is a negative regulator of JunH Sato, H Takeshita, M Furukawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1983
Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNAM Seiki, S Hattori, Y Hirayama, et al.
Pageof 24

Showing results (41-50 of 235) with videos related to

Sort By:
Pageof 24
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 1, 1984
[Adult T-cell leukemia virus (ATLV or HTLV) proviral DNA for the classification of T-cell malignancies]K Yamaguchi, K Takatsuki, M Seiki, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1984
Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the diseaseM Yoshida, M Seiki, K Yamaguchi, et al.
Genome|January 1, 1989
Molecular mechanisms of regulation of HTLV-1 gene expression and its association with leukemogenesisM Yoshida, J Inoue, J Fujisawa, et al.
FEBS Letters|February 3, 1997
Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activatorY Okumura, H Sato, M Seiki, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Cell type-specific involvement of furin in membrane type 1 matrix metalloproteinase-mediated progelatinase A activationT Sato, T Kondo, M Seiki, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1988
Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type IM Seiki, J Inoue, M Hidaka, et al.
Clinical & Experimental Metastasis|March 10, 2001
Heat shock-mediated transient increase in intracellular 3',5'-cyclic AMP results in tumor specific suppression of membrane type 1-matrix metalloproteinase production and progelatinase A activationY Sawaji, T Sato, M Seiki, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 1, 1995
[Expression of membrane-type matrix metalloproteinase (MT-MMP) and activation of MMP-2 in lung cancer]M Tokuraku, H Sato, Y Watanabe, et al.
Journal of Virology|August 1, 1992
Epstein-Barr virus BZLF1 transactivator is a negative regulator of JunH Sato, H Takeshita, M Furukawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1983
Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNAM Seiki, S Hattori, Y Hirayama, et al.
Pageof 24